𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravenous (IV) Busulfan (Bu) Administered Twice Daily During Conditioning Prior to Allogeneic Stem Cell Transplant (AlloSCT) in Pediatric Recipients Has Significantly Different Half-Life of Elimination and Clearance in Recipients >4 Years and Those ≤ 4 Years

✍ Scribed by J.B. LeGall; M. Milone; I. Waxman; L. Shaw; L. Harrison; D. Duffy; C. van de Ven; O. Militano; M. Geyer; E. Morris; L. Baxter Lowe; M.S. Cairo

Book ID
116283071
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
70 KB
Volume
18
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

229: Twice-Daily Intravenous (IV) Busulf
229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults
✍ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB